Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hBMMSC injection in autoimmune pulmonary alveolar proteinosis (Phase IIa, open-label)
CTR20233275Phase 2Active
- Sponsor
- Jiuzhitang Meike
- Start
- Oct 2023
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human bone marrow mesenchymal stem cell injection in autoimmune pulmonary alveolar proteinosis (aPAP), sponsored by Jiuzhitang Meike. Started Oct 2023; status: active.
02
Drugs
human bone marrow mesenchymal stem cell injection
03
Conditions
autoimmune pulmonary alveolar proteinosis (aPAP)
Beyond the preview
Go deeper on CTR20233275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233275.